Cart 0 Product Products (empty)
No products
To be determined Shipping
0,00 € Total
Prices are tax excluded
Product successfully added to your shopping cart
Quantity
Total
There are 0 items in your cart. There is 1 item in your cart.
Total products (tax excl.)
Total shipping (tax excl.) To be determined
Total (tax excl.)
Data sheet of IDO2 polyclonal antibody
| Brand | Abnova |
| Product type | Primary antibodies |
| Reactivity | Human |
| Host species | Goat |
| Applications | ELISA,WB-Ti |
More info about IDO2 polyclonal antibody
| Brand: | Abnova |
| Reference: | PAB17233 |
| Product name: | IDO2 polyclonal antibody |
| Product description: | Goat polyclonal antibody raised against synthetic peptide of IDO2. |
| Gene id: | 169355 |
| Gene name: | IDO2 |
| Gene alias: | INDOL1 |
| Gene description: | indoleamine 2,3-dioxygenase 2 |
| Immunogen: | A synthetic peptide corresponding to human IDO2. |
| Immunogen sequence/protein sequence: | C-RDKTLESILHPR |
| Protein accession: | NP_919270.2 |
| Form: | Liquid |
| Concentration: | 0.5 mg/mL |
| Recommend dilutions: | ELISA (1:64000) Western Blot (1-3 ug/mL) The optimal working dilution should be determined by the end user. |
| Storage buffer: | In Tris saline, pH 7.3 (0.5% BSA, 0.02% sodium azide) |
| Storage instruction: | Store at -20°C. Aliquot to avoid repeated freezing and thawing. |
| Note: | This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only. |
| Product type: | Primary antibodies |
| Host species: | Goat |
| Antigen species / target species: | Human |
| Reactivity: | Human |
| Application image: |  |
| Application image note: | IDO2 polyclonal antibody (Cat # PAB17233) (0.5 ug/mL) staining of human kidney lysate (35 ug protein in RIPA buffer) with (B) and without (A) blocking with the immunising peptide. Primary incubation was 1 hour. Detected by chemiluminescence. |
| Applications: | ELISA,WB-Ti |
| Shipping condition: | Dry Ice |
| Publications: | Novel tryptophan catabolic enzyme IDO2 is the preferred biochemical target of the antitumor indoleamine 2,3-dioxygenase inhibitory compound D-1-methyl-tryptophan.Metz R, Duhadaway JB, Kamasani U, Laury-Kleintop L, Muller AJ, Prendergast GC. Cancer Res. 2007 Aug 1;67(15):7082-7. |